Blood Res.
2023 Apr;58(S1):1-7. 10.5045/br.2023.2023004.
Transfusion support in hematopoietic stem cell transplantation
- Affiliations
-
- 1Departments of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, Seoul, Korea
- 2Departments of Laboratory Medicine, Incheon St. Mary’s Hospital, College of Medicine, Incheon, Korea
- 3Departments of Laboratory Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2541975
- DOI: http://doi.org/10.5045/br.2023.2023004
Abstract
- Transfusion support for hematopoietic stem cell transplantation (HSCT) is an essential part of supportive care, and compatible blood should be transfused into recipients. As leukocyte antigen (HLA) matching is considered first and as the blood group does not impede HSCT, major, minor, bidirectional, and RhD incompatibilities occur that might hinder transfusion and cause adverse events. Leukocyte reduction in blood products is frequently used, and irradiation should be performed for blood products, except for plasma. To mitigate incompatibility and adverse events, local transfusion guidelines, hospital transfusion committees, and patient management should be considered.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Opening the era of in vivo xenotransplantation model for hematopoietic stem cell transplantation
- Hematopoietic Stem Cell Transplantation
- Transfusion in RhD Mismatch Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation in Inborn Error of Metabolism
- A Study of the Factors Affecting the Term of Engraftment During Hematopoietic Stem Cell Transplantation with a Focus on the Inhibitors of Oral Intake and the Period of Nutritional Support
